Scinai Immunotherapeutics (SCNI) Short-term Investments (2016 - 2025)

Scinai Immunotherapeutics has disclosed Short-term Investments across 7 years of filings, most recently posting $150000.0 for Q4 2025.

• Short-term Investments for Q4 2025 came in at $150000.0, up 14.5% year-over-year; the trailing twelve-month figure through Dec 2025 was $150000.0 (up 14.5% YoY), and the FY2025 annual result was $150000.0, up 14.5% from the prior year.
• Short-term Investments came in at $150000.0 for Q4 2025 at Scinai Immunotherapeutics, up from $142000.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $150000.0 in Q4 2025 to a low of $122000.0 in Q3 2023.
• The 5-year median for Short-term Investments is $138000.0 (2022), against an average of $136428.6.
• Across the five-year window, Short-term Investments dropped 10.29% in 2023 and rose 14.5% in 2025, its largest moves.
• Scinai Immunotherapeutics' Short-term Investments stood at $143000.0 in 2021, then fell by 2.1% to $140000.0 in 2022, then changed by 0.0% to $140000.0 in 2023, then fell by 6.43% to $131000.0 in 2024, then gained by 14.5% to $150000.0 in 2025.
• The last three Short-term Investments figures came in at $150000.0 (Q4 2025), $142000.0 (Q2 2025), and $131000.0 (Q4 2024), per Business Quant data.